云南白药 (000538) 财务报表

截止日期2022-09-302022-06-302022-03-312021-12-312021-09-30
营业总收入(万元)2691568.971801673.86942953.993637391.902836252.25
营业收入(万元)2691568.971801673.86942953.993637391.902836252.25
营业总成本(万元)2309681.311524579.73774178.643173981.822442980.18
营业成本(万元)1932179.631279249.81658770.562649843.512040973.69
净利润(万元)214023.33136640.9890356.41279633.60245217.34
归属于母公司的净利润(万元)230489.63150049.4691436.82280362.16245053.40
营业利润(万元)253685.20165804.11108400.22348516.85298776.64
利润总额(万元)253672.17165665.98108381.91348164.62298600.95
少数股东损益(万元)-16466.30-13408.48-1080.42-728.55163.93
基本每股收益(元)1.53(元)1.10(元)0.71(元)2.21(元)1.92(元)
稀释每股收益(元)1.52(元)1.09(元)0.71(元)2.18(元)1.91(元)
非经常性损益(万元)-39985.36-15405.57-40534.83-53500.35-48079.90
扣除非经常性损益后净利润(万元)270474.99165455.03131971.66333862.51293133.30
总资产(万元)5168448.354990122.335311999.325229276.565223370.79
总负债(万元)1377121.891271134.201363933.081385894.781407887.83
归属于母公司股东权益合计(万元)3782721.873706764.573915478.793822613.693793855.44
股东权益合计(万元)3791326.463718988.143948066.243843381.783815482.96
实收资本(股本)(万元)179686.25179686.25128298.76128271.52128259.41
资本公积(万元)1827154.651826407.851814628.921812639.361819326.57
未分配利润(万元)1602292.021521851.851719842.351628405.531637501.99
经营活动产生的现金流量净额(万元)194227.95117795.01-17030.69522327.83653392.33
经营活动现金流入小计(万元)2863786.451904177.48901745.344039278.393212827.46
经营活动现金流出小计(万元)2669558.501786382.48918776.043516950.562559435.12
投资活动产生的现金流量净额(万元)-653547.47-725484.73-816668.19399869.63143134.63
投资活动现金流入小计(万元)595278.63512293.99409200.781089434.59492779.94
投资活动现金流出小计(万元)1248826.101237778.721225868.97689564.95349645.31
筹资活动产生的现金流量净额(万元)-284854.05-271267.4914300.98-462268.27-455659.73
筹资活动现金流入小计(万元)209230.57162032.1188598.40317302.48152935.60
筹资活动现金流出小计(万元)494084.63433299.6074297.42779570.75608595.32
期末现金及现金等价物余额(万元)1142221.621008739.501066975.401886986.481767701.76
最后修改日期2022-10-272022-08-292022-04-282022-03-262021-11-13